Nordic Life Science 1
H E Y T H E R E | C L I N I C A L T R I A L S | I
N A N E W JO B | P R O F I L E In June, Carlos de Sousa commenced his role as Chief Executive Officer at Norwegian Ultimovacs, a pharmaceutical company developing novel immunotherapies against cancer READ MORE ON PAGE 24 For some people, testing the same thing over and over would seem tedious. For Charlotte Aagaard, final results achieved through trialand-error are what fuel her passion for her career. READ MORE ON PAGE 26 A+ Science has a new CEO, Sobi a new Head of R&D, FIMM has appointed a new Head of its Metabolomics unit, and LEO Pharma has a new EVP Global Therapeutic & Value Strategy. READ MORE ON PAGE 30 What began as a project for Evelina Vågesjö’s doctoral thesis grew into groundbreaking drug candidates and delivery methods, followed not long afterwards, by a clinical-stage company. READ MORE ON PAGE 32 NORDIC LIFE SCIENCE 23 PHOTO JENNY ÖHMAN